§ 12-6A-06
120 words·~1 min read·
/md/health-occupations/12-6a-06·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
§12–6A–06.
(a)A protocol under this subtitle:
(1)May authorize:
(i)For protocols by a licensed physician and licensed pharmacist, the initiation of drug therapy under written, disease–state specific protocols;
(ii)The modification, continuation, and discontinuation of drug therapy under written, disease–state specific protocols;
(iii)The ordering of laboratory tests; and
(iv)Other patient care management measures related to monitoring or improving the outcomes of drug or device therapy; and
(2)May not authorize acts that exceed the scope of practice of the parties to the therapy management contract.
(b)A protocol shall prohibit the substitution of a chemically dissimilar drug product by the pharmacist for the product prescribed by the authorized prescriber, unless permitted in the therapy management contract.